Buck Wealth Strategies’s AbbVie ABBV Stock Holding History

Buck Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399K	Sell	1,587 -140	-8%	-$30.1K	0.04%	142
2026 Q1	$376K	Sell	1,727 -117	-6%	-$26K	0.05%	118
2025 Q4	$421K	Sell	1,844 -185	-9%	-$42.1K	0.05%	111
2025 Q3	$470K	Sell	2,029 -180	-8%	-$36.7K	0.06%	121
2025 Q2	$410K	Buy	2,209 +728	+49%	+$135K	0.06%	105
2025 Q1	$310K	Buy	+1,481	New	+$288K	0.06%	105
2023 Q4	–	Sell	-37,907	Closed	-$5.65M	–	64
2023 Q3	$5.65M	Buy	37,907 +299	+0.8%	+$43.9K	2.27%	19
2023 Q2	$5.07M	Buy	37,608 +4,332	+13%	+$635K	2.2%	25
2023 Q1	$5.3M	Buy	+33,276	New	+$5.09M	2.59%	10
2022 Q3	$5.21M	Buy	+34,949	New	+$5.02M	2.44%	19

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Buck Wealth Strategies's ABBV Position: Q2 2026 in Review

Buck Wealth Strategies reduced its AbbVie (ABBV) stake by 8.1% in Q2 2026, selling an estimated $30.1K and leaving 1,587 shares worth $399K. The position accounts for 0.04% of the portfolio, ranked #142.

Buck Wealth Strategies first reported a position in ABBV in Q3 2022 and has held it in 10 quarters since. The position peaked at $5.65M in Q3 2023. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Buck Wealth Strategies held 1,587 shares of AbbVie worth $399K as of Q2 2026.
Buck Wealth Strategies sold 140 AbbVie shares in Q2 2026, an estimated $30.1K.
AbbVie made up 0.04% of Buck Wealth Strategies's portfolio in Q2 2026, its #142 holding.
Buck Wealth Strategies first reported a position in AbbVie in Q3 2022 and has held it in 10 quarters since.
Buck Wealth Strategies's AbbVie position peaked at $5.65M in Q3 2023.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.